e-Therapeutics (LSE:ETX) Accounts Payable & Accrued Expense : £1.19 Mil (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Accounts Payable & Accrued Expense?

e-Therapeutics's quarterly accounts payable & accrued expense declined from Jul. 2022 (£0.69 Mil) to Jan. 2023 (£0.62 Mil) but then increased from Jan. 2023 (£0.62 Mil) to Jul. 2023 (£1.19 Mil).

e-Therapeutics's annual accounts payable & accrued expense increased from Jan. 2021 (£0.18 Mil) to Jan. 2022 (£0.24 Mil) and increased from Jan. 2022 (£0.24 Mil) to Jan. 2023 (£0.62 Mil).

e-Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for e-Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Accounts Payable & Accrued Expense Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.23

0.22

0.18

0.24

0.62

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.85	0.24	0.69	0.62	1.19

e-Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

e-Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ETXPF:USA

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021